<DOC>
	<DOCNO>NCT01677065</DOCNO>
	<brief_summary>To determine whether bioavailability controlled-release test formulation least high commercial reference drug .</brief_summary>
	<brief_title>A Randomized , Two-way , Crossover Study Estimate Relative Bioavailability Controlled-release Formulation Oxycodone ( 40 mg ) With Sequestered Naltrexone Compared With Immediate-release Oxycodone Tablets ( 20 mg ) Healthy Volunteers</brief_title>
	<detailed_description>Serial sample venous blood</detailed_description>
	<mesh_term>Naltrexone</mesh_term>
	<mesh_term>Oxycodone</mesh_term>
	<criteria>healthy volunteer , great 50 kg , able willing sign inform consent Evidence significant illness , condition affect drug absorption , history sleep apnea , allergy opioid drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Bioavailability</keyword>
	<keyword>Oxycodone</keyword>
	<keyword>Healthy Volunteers</keyword>
</DOC>